Matthew Ellis Marting Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12006 Manchester Road, St Louis, MO 63131 Phone: 314-965-0030 |
Mr. Curtis A Young, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5471 Dr Martin Luther King Drive, St Louis, MO 63112 Phone: 314-367-5820 Fax: 314-367-7010 |
Mrs. Angela M Reed, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 115 A N Euclid, St Louis, MO 63108 Phone: 314-454-6676 |
Asma F Raza, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 915 N Grand Ave., 119 Jc, St Louis, MO 63106 Phone: 314-289-6439 |
Dan White, RPN Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4700 North Hanley Rd, Suite A, St Louis, MO 63368 Phone: 314-475-6101 |
Mrs. Barbara Jean Faber, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1035 Bellevue Avenue, St Louis, MO 63117 Phone: 314-768-8870 Fax: 314-768-8871 |
Rachel Hartman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 115a N Euclid, St Louis, MO 63108 Phone: 314-454-6676 |
Richard M Miller, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4512 Lemay Ferry Rd, St Louis, MO 63129 Phone: 314-894-6893 |
Mrs. Ivy Ann Desiree Lee Sharpe, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5471 Dr Martin Luther King Drive, St Louis, MO 63112 Phone: 314-367-5820 Fax: 314-367-7010 |
News Archive
The National Cancer Institute has awarded USC scientists $3.5 million for a study of the enzyme that faithfully copies our genetic information, enabling it to pass from one generation to the next. The grant will fund structural, biochemical and computer studies designed to reveal how the enzyme, DNA polymerase, makes so few mistakes.
As they develop, vertebrate embryos form vertebrae in a sequential, time-controlled way. Scientists have determined previously that this process of body segmentation is controlled by a kind of "clock," regulated by the oscillating activity of certain genes within embryonic cells. But questions remain about how precisely this timing system works.
The National Comprehensive Cancer Network Oncology Research Program has funded two investigators from NCCN Member Institutions through a collaborative scientific research relationship with AstraZeneca to further evaluate the clinical effectiveness of osimertinib in the treatment of epidermal growth factor receptor-positive (EGFRm+) non-small cell lung cancer (NSCLC).
A made-in-Singapore cancer drug has advanced into clinical trials, charting a milestone in Singapore's biomedical sciences initiative that will go towards improving the lives of cancer patients in Singapore, and worldwide.
› Verified 7 days ago